Personalis, Inc. SEC filings PSNL
Personalis, Inc. has 556 filings in SEC EDGAR's recent list, going back to Aug 15, 2011. Its latest annual report, Form ARS, was filed on Apr 2, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 425 | Filing | Nov 6, 2026 | — |
| 425 | Filing | Nov 3, 2026 | — |
| 425 | Filing | Oct 30, 2026 | — |
| 425 | Filing | Oct 21, 2026 | — |
| 425 | Filing | Oct 20, 2026 | — |
| 425 | Filing | Oct 6, 2026 | — |
| CT ORDER | Filing | Oct 2, 2026 | — |
| 425 | Filing | Sep 15, 2026 | — |
| 425 | Filing | Jul 20, 2026 | — |
| 425 | Filing | Jul 20, 2026 | — |
| 425 | Filing | Jul 20, 2026 | — |
| 425 | Filing | Jul 20, 2026 | — |
| 425 | Filing | Jul 20, 2026 | — |
| 425 | Filing | Jul 20, 2026 | — |
| EFFECT | Filing | Apr 3, 2025 | — |
| CORRESP | Letter to the SEC | Apr 1, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 6, 2025 | — |
| EFFECT | Filing | Sep 11, 2024 | — |
| CORRESP | Letter to the SEC | Sep 9, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 9, 2024 | — |
| EFFECT | Filing | Jan 9, 2024 | — |
| EFFECT | Filing | Jan 8, 2024 | — |
| CORRESP | Letter to the SEC | Jan 5, 2024 | — |
| CORRESP | Letter to the SEC | Jan 4, 2024 | — |
| CORRESP | Letter to the SEC | Jan 4, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 3, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 3, 2024 | — |
| EFFECT | Filing | Jan 8, 2021 | — |
| CORRESP | Letter to the SEC | Jan 6, 2021 | — |
| UPLOAD | Letter from the SEC | Jan 5, 2021 | — |
| EFFECT | Filing | Jul 10, 2020 | — |
| CORRESP | Letter to the SEC | Jul 8, 2020 | — |
| UPLOAD | Letter from the SEC | Jul 7, 2020 | — |
| EFFECT | Filing | Jun 19, 2019 | — |
| CERT | 8a cert | Jun 18, 2019 | — |
| CORRESP | Letter to the SEC | Jun 17, 2019 | — |
| CORRESP | Letter to the SEC | Jun 17, 2019 | — |
| 8-A12B | Filing | Jun 17, 2019 | — |
| SEC STAFF LETTER | Filing | Jun 13, 2019 | — |
| CORRESP | Letter to the SEC | Jun 4, 2019 | — |
| SEC STAFF LETTER | Filing | May 15, 2019 | — |
| DRSLTR | Filing | May 10, 2019 | — |
| DRS/A | Filing | May 10, 2019 | — |
| UPLOAD | Letter from the SEC | Apr 23, 2019 | — |
| DRS | Filing | Mar 27, 2019 | — |
| D | Filing | Jul 18, 2017 | — |
| D | Filing | Dec 30, 2014 | — |
| D | Filing | Oct 9, 2013 | — |
| D | Filing | Aug 15, 2011 | — |
Showing 49 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- PSNL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Fremont, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1527753
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.